Search for: "Five Five's Properties, Inc." Results 321 - 340 of 2,878
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
10 Nov 2021, 1:13 pm by admin
Jordan Walsh, Shaun Kennedy, and Brit (Brittany) Merrill ERE Recruiting Intelligence Republished with permission ERE Media, Inc. [read post]
3 Nov 2021, 10:26 am by John Elwood
The court denied review in Dignity Health, Inc. v. [read post]
14 Oct 2021, 2:50 pm by Eugene Volokh
" Although Congress made specific commerce findings regarding religious real property, it made no such findings relating to § 248(a)(2), which importantly regulates violence against persons, not real property…. [read post]
11 Oct 2021, 8:16 am by Cinthia Macie
 If you are interested in the new fields being plowed by antitrust enforcers, here are five developments you should be aware of and consider monitoring. 1) The Biden Administration Has Its Eyes on Agricultural Sector In July 2021, President Biden issued an Executive Order on Promoting Competition in the American Economy. [read post]
4 Oct 2021, 6:24 am by Shannon O'Hare
Under the German LMA standard, borrower consent is deemed to have been given five business days after request, if not expressly refused by the borrower within that timeframe. [read post]
26 Sep 2021, 7:09 pm by Aaron Moss
That’s because the creative properties at issue have been developed over many years with the addition of ancillary stories, characters and character attributes contributed by people other than the characters’ original writers and artists. [read post]
24 Sep 2021, 4:12 am by Merpel McKitten
Supreme Court in an amicus brief that “licensing its intellectual property to entities that produce (non-Qualcomm) chips” was one of its “primary sources of revenue” and that “Qualcomm has provided chipmakers nontransferable, worldwide, nonexclusive, restricted licenses to its portfolio of technically necessary patents. [read post]
In undoubtedly one of the most important decisions of the year so far, on 24 August 2021, the English Court of Appeal handed down its judgment in FibroGen v Akebia (FibroGen Inc v Akebia Therapeutics Inc [2021] EWCA Civ 1279), partially allowing FibroGen’s appeal, and so finding one of the ‘Family A’ patents, EP 823, valid and infringed. [read post]